Pressefach

AUSSENDER



QIAGEN N.V.
Ansprechpartner: Investor Relations
Tel.: +31 7735566 - 00
E-Mail: ir@qiagen.com
Pressefach

Schlagwörter

QIAGEN N.V.
Stimmrechtsanteile
Voting rights
02.01.2023 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
02.01.2023 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
02.01.2023 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
27.12.2022 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
21.12.2022 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
21.12.2022 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
16.12.2022 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
16.12.2022 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
16.12.2022 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
09.12.2022 - 22:10 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
02.12.2022 - 22:15 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
02.12.2022 - 22:15 | QIAGEN N.V.
Managers' transactions announcement according to article 19 MAR
02.12.2022 - 22:15 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
28.11.2022 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
zurück
Artikel 226 - 240
|
99.112 Abonnenten
|
221.766 Meldungen
|
90.628 Pressefotos
|
Folgen Sie uns auf Twitter
Top